MYRX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 22:57):

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc...

Stats
今日成交量	91.00
平均成交量	1 084.00
市值	4.14M
EPS	$-0.110 ( 2013-05-10 )
Last Dividend	$2.86 ( 2013-02-19 )
Next Dividend	$0 ( N/A )
P/E	-0.350
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2013-01-22	Couchman Jonathan	Buy	0
2013-01-18	Henderson John T	Buy	2 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock
2013-01-18	Henderson John T	Buy	7 500	Common Stock

INSIDER POWER
0.00
Last 67 transactions
Buy: 851 709 \| Sell: 32 578

Myrexis, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Financial Reports:

No articles found.

Myrexis, Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Myrexis, Inc. Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$2.86	2013-02-19
Last Dividend	$2.86	2013-02-19
Next Dividend	$0	N/A
Payout Date	2013-02-15
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$2.86	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-05)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
RKAGY	Ex Dividend Junior	2023-06-08	Annually	0.00%
EPOKY	Ex Dividend Knight	2023-10-23	Semi-Annually	0.00%
WTBFB	Ex Dividend Junior	2023-09-07	Quarterly	0.00%
LLESY	Ex Dividend Junior	2023-08-24	Semi-Annually	0.00%
CCHGY	Ex Dividend Knight	2023-05-25	Annually	0.00%
SMAL	Ex Dividend Knight	2023-08-24	Quarterly	0.00%
FSUGY	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
NABZY	Ex Dividend Junior	2023-05-12	Semi-Annually	0.00%
CNLHP	Ex Dividend Junior	2023-08-09	Quarterly	0.00%
TGOPY	Ex Dividend Knight	2023-06-22	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-9.39	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.257	1.500	-3.96	-5.95	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	16.72	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	16.35	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	15.34	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.417

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	-0.257	2.50	-2.55	-5.95	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.397

Myrexis, Inc.

Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.